Management of Excessive Secretions After Tracheostomy for Lower Tracheal Obstruction

Evidence-Based Rationale

The American College of Chest Physicians recommends non-invasive mechanical ventilation as a primary intervention for managing excessive secretions and improving the patient's condition after tracheostomy placement for central airway obstruction with tracheobronchomalacia or excessive dynamic airway collapse 1, 2, 3
The American College of Chest Physicians guidelines suggest that evidence supports the utility of noninvasive ventilation as a primary intervention for nonmalignant central airway obstruction associated with tracheobronchomalacia and excessive dynamic airway collapse 1, 2, 3

Non-invasive ventilation provides positive pressure support that stents open collapsible airways, preventing dynamic collapse during expiration and facilitating secretion clearance 1, 3
Non-invasive ventilation can be delivered through the tracheostomy tube, creating a "closed system" that maintains positive airway pressure while allowing for controlled secretion management 4

Oxygen supplementation alone does not address the mechanical problem of airway collapse or impaired secretion clearance 1
Supplemental oxygen may mask hypoventilation without treating the underlying pathophysiology 5
Negative pressure ventilation is obsolete and not mentioned in any contemporary airway management guidelines 1, 2, 3
Negative pressure ventilation would worsen dynamic airway collapse by creating more negative intrathoracic pressure 1
Spirometry is a diagnostic test, not a therapeutic intervention 1
Spirometry has no role in acute management of secretions or airway obstruction 5

Confirm tracheostomy tube patency by passing a soft suction catheter through the tube 5, 6
Apply non-invasive ventilation through the tracheostomy using appropriate settings (typically pressure support 8-12 cmH₂O with PEEP 5-8 cmH₂O) 1
Ensure adequate humidification (minimum 30 mg H₂O per liter at 30°C) to prevent secretion thickening 6
Perform regular suctioning with pre-marked catheters, twirling during withdrawal 6

Consider mucolytic therapy (acetylcysteine or hypertonic saline nebulizers) for thick secretions 6, 7
Maintain cuff pressure at 20-30 cmH₂O if cuffed tube is used, checking every 8 hours 7
Monitor with pulse oximetry and waveform capnography continuously 8

Never attempt vigorous positive pressure ventilation through a potentially displaced tube, as this forces air into tissue planes causing surgical emphysema and pneumothorax 5, 8
Do not use rigid introducers or bougies to assess tube patency, as these can create false passages 8
Avoid high-flow oxygen therapies without positive pressure support in patients with dynamic airway collapse, as they provide no mechanical airway support 1

For patients with severe tracheobronchomalacia refractory to non-invasive ventilation, consider a stent trial followed by tracheobronchoplasty 1, 3